Dana Mahmood
Overview
Explore the profile of Dana Mahmood including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peters B, Beige J, Siwy J, Rudnicki M, Wendt R, Ortiz A, et al.
Nephrol Dial Transplant
. 2023 Jun;
38(12):2826-2834.
PMID: 37349951
Background: Immunoglobulin A nephropathy (IgAN) frequently leads to kidney failure. The urinary proteomics-based classifier IgAN237 may predict disease progression at the time of kidney biopsy. We studied whether IgAN237 also...
2.
Mahmood D, Stegmayr B
Blood Purif
. 2018 Jul;
46(3):257-263.
PMID: 29972824
Anticoagulation with citrate-containing haemodialysate (cHD) is an alternative to tinzaparin haemodialysate (tHD). The study investigated whether cHD would differ when changed from tHD. The same 18 patients were their own...
3.
Mahmood D, Makoveichuk E, Nilsson S, Olivecrona G, Stegmayr B
Int J Artif Organs
. 2014 Mar;
37(1):13-20.
PMID: 24634330
Background/aim: Patients on chronic hemodialysis (cHD) have decreased activity of lipoprotein lipase (LPL). Angiopoietin-like proteins (ANGPTL) 3 and 4 have been shown to inactivate LPL. The aim of this study...
4.
Mahmood D, Nilsson S, Olivecrona G, Stegmayr B
Scand J Clin Lab Invest
. 2014 Feb;
74(4):296-300.
PMID: 24564630
Background: The lipoprotein lipase (LPL) pool is reduced by 50% in patients on hemodialysis (HD). LPL release by tinzaparin has not been investigated for peritoneal dialysis (PD). Therefore, the aim...
5.
Stegmayr B, Jonsson P, Mahmood D
Int J Artif Organs
. 2013 Jan;
36(1):1-6.
PMID: 23280073
Background: The blood membrane interaction induced during hemodialysis (HD) activates the coagulation system. To prevent clotting and to maintain dialyzer patency, an anticoagulant such as tinzaparin is used. To increase...
6.
Mahmood D, Grubbstrom M, Lundberg L, Olivecrona G, Olivecrona T, Stegmayr B
BMC Nephrol
. 2010 Dec;
11:33.
PMID: 21129229
Background: Low molecular weight (LMW) heparins are used for anticoagulation during hemodialysis (HD). Studies in animals have shown that LMW-heparins release lipoprotein lipase (LPL) as efficiently as unfractionated (UF) heparin,...